GeneDx Holdings Integrates Genetic Testing with Epic Aura for Enhanced Clinical Efficiency

GeneDx Enhances Genetic Testing through Epic Integration

GeneDx Holdings, a leader in genomic insights, recently advances the field of genetic diagnostics by launching its services on Epic’s specialty diagnostics suite, Aura. This integration represents a significant milestone for healthcare providers, as it allows them to order and receive results for various GeneDx diagnostic tests—including exome sequencing (ES), whole genome sequencing (WGS), and rapid whole genome sequencing (rWGS)—directly within electronic health records (EHR). By embedding genetic testing into the EHR framework, GeneDx aims to streamline the complex genetic testing process, making it more accessible and efficient for clinicians and patients alike.

The integration with Epic Aura is particularly noteworthy as it enhances the visibility of genetic test results among other laboratory findings, a feature acknowledged by Dr. Michael Adams from UNC Health, the first health system to implement this integration. This visibility not only facilitates the diagnostic process but also contributes to research and quality improvement initiatives in clinical settings. By enabling healthcare providers to view genetic insights alongside traditional lab results, the integration supports an informed decision-making process that can lead to more accurate diagnoses and tailored treatment plans for patients suffering from genetic conditions.

Katherine Stueland, President and CEO of GeneDx, emphasizes the company's dedication to patient-centered solutions, noting that approximately 80% of genetics experts currently rely on GeneDx for their genetic testing needs. With a proven track record of sequencing over 750,000 exomes and genomes, GeneDx possesses one of the largest rare disease datasets, reinforcing its leadership in the genomic testing industry. As more health systems adopt GeneDx's services through the Aura platform, the integration is set to enhance routine clinical practice across various specialties, including pediatrics and genetics, ultimately accelerating treatment timelines and improving patient outcomes.

GeneDx’s collaboration with Epic is a promising development in the realm of genomic medicine, signifying a shift towards more integrated healthcare solutions. This initiative not only streamlines the testing process but also empowers clinicians with critical insights that can transform patient care.

As the adoption of GeneDx’s services expands within health systems, the company is well-positioned to become an integral part of the evolving landscape of genetic testing. For those interested in exploring the capabilities of GeneDx’s integration with Epic Aura, additional information is available on their dedicated website.